Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress

References

• Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmology 34356, eCollection 2013.
   Google Scholar
• Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 1998;21:1230–5. doi: 10.2337/diacare.21.8.1230
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010;304:649–56. doi: 10.1001/jama.2010.1111
   PubMed Web of Science ®Google Scholar
• Naruse R, Suetsugu M, Terasawa T, Ito K, Hara K, Takebayashi K, et al. Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes. Saudi Medi J 2013;34:135–141.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Carrizalez AD, Castellanos-González JA, Martínez-Romero EC, Miller-Arrevillaga G, Villa-Hernández D, Hernández-Godínez PP, et al. Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy. J Diabetes 2014;6:167–75. doi: 10.1111/1753-0407.12076
   PubMed Web of Science ®Google Scholar
• Patel C, Rojas M, Narayanan SP, Zhang W, Xu Z, Lemtalsi T, et al. Arginase as a mediator of diabetic retinopathy. Front Immunol 2013;4:173. doi: 10.3389/fimmu.2013.00173
   PubMed Web of Science ®Google Scholar
• Pannu R, Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int 2006;49:170–80. doi: 10.1016/j.neuint.2006.04.010
   PubMed Web of Science ®Google Scholar
• Semba RD, Huang H, Lutty GA, Van Eyk JE, Hart GW. The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Proteom Clin Appl 2014;8:218–31. Doi:10.1002/prca.201300076.
   PubMed Web of Science ®Google Scholar
• Ezquer F, Ezquer M, Arango-Rodriguez M, Conget P. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy? Acta Ophthalmol 2014;92:e86–95. doi: 10.1111/aos.12113
   Google Scholar
• Kuo JZ, Guo X, Klein R, Klein BE, Genter P, Roll K, et al. Adiponectin, insulin sensitivity and diabetic retinopathy in Latinos with type 2 diabetes. J Clin Endocrinol Metab 2015;10:3348–55. Doi:10.1210/jc.2015-1221.
   PubMed Web of Science ®Google Scholar
• Bucolo C, Marrazzo G, Platania CB, Drago F, Leggio GM, Salomone S. Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy. J Diabetes Res 2013; 2013:1–6, article no. 432695. Doi:10.1155/2013/432695.
   PubMed Web of Science ®Google Scholar
• Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, et al. Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009;15:1298–306. doi: 10.1038/nm.2052
   PubMed Web of Science ®Google Scholar
• Devi TS, Hosoya K, Terasaki T, Singh LP. Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy. Exp Cell Res 2013;319:1001–12. doi: 10.1016/j.yexcr.2013.01.012
   PubMed Web of Science ®Google Scholar
• Chiu CJ, Taylor A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res 2011;30:18–53. doi: 10.1016/j.preteyeres.2010.09.001
   PubMed Web of Science ®Google Scholar
• Williams M, Hogg RE, Chakravarthy U. Antioxidants and diabetic retinopathy. Curr Diabetes Rep 2013;13:481–7. doi: 10.1007/s11892-013-0384-x
   PubMed Web of Science ®Google Scholar
• Chen H, Wen F, Zhang X, Su SB. Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. Mol Vis 2012;18:219–26.
   PubMed Web of Science ®Google Scholar
• Papavasileiou E, Dereklis D, Oikonomidis P, Grixti A, Vineeth Kumar B, Prasad S, et al. An effective programme to systematic diabetic retinopathy screening in order to reduce diabetic retinopathy blindness. Hellenic J Nucl Med 2014;17(Suppl 1):30–34.
   PubMedGoogle Scholar
• Ryeom S, Folkman J. Role of endogenous angiogenesis inhibitors in Down syndrome. J Craniofacial Surg 2009;20(Suppl 1):595–6. doi: 10.1097/SCS.0b013e3181927f47
   PubMed Web of Science ®Google Scholar
• Brondani LA, de Souza BM, Duarte GC, Kliemann LM, Esteves JF, Marcon AS, et al. The UCP1−3826A/G polymorphism is associated with diabetic retinopathy and increased UCP1 and MnSOD2 gene expression in human retina. Invest Ophthalmol Vis Sci 2012;53:7449–57. doi: 10.1167/iovs.12-10660
   PubMed Web of Science ®Google Scholar
• Payne AJ, Kaja S, Naumchuk Y, Kunjukunju N, Koulen P. Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina. Int J Mol Sci 2014;15:1865–86. doi: 10.3390/ijms15021865
   PubMed Web of Science ®Google Scholar
• Njie-Mbye YF, Kulkarni-Chitnis M, Opere CA, Barrett A, Ohia SE. Lipid peroxidation: pathophysiological and pharmacological implications in the eye. Front Physiol 2013;4:366, eCollection. doi: 10.3389/fphys.2013.00366
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992;119:598–620.
   PubMed Web of Science ®Google Scholar
• Gaál T, Speake BK, Mezes M, Noble RC, Surai PF, Vajdovich P. Antioxidant parameters and ageing in some animal species. Comp Haematol Int 1996;6:208–13. doi: 10.1007/BF00378112
   Google Scholar
• Miller JK, Brzezinska-Slebodzinska E, Madsen FC. Oxidative stress, antioxidants, and animal function. J Dairy Sci 1993;76:2812–23. doi: 10.3168/jds.S0022-0302(93)77620-1
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1–14. doi: 10.1042/bj2190001
   PubMed Web of Science ®Google Scholar
• Juarez Olguín H, Calderon Guzman D. Free radicals: formation, types and effects in Central Nervous System. In: Dimitri K, Vasily S, (eds.) Handbook of free radicals: formation, types and effects. New York: Nova Science Publishers; 2009. p. 539–56.
   Google Scholar
• Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005;8:1140–9. doi: 10.1089/ars.2005.7.1140
   Web of Science ®Google Scholar
• Santos JM, Mishra M, Kowluru RA. Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon. Exp Eye Res 2014;121C:168–77. doi: 10.1016/j.exer.2014.02.010
   Web of Science ®Google Scholar
• McAuley AK, Wang JJ, Dirani M, Connell PP, Lamoureux E, Hewitt AW. Replication of genetic loci implicated in diabetic retinopathy. Invest Ophthalmol Vis Sci 2014; pii: iovs.13-13559v1. Doi:10.1167/iovs.13-13559.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Zhong Q, Santos JM, Thandampallayam M, Putt D, Gierhart DL. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metabol 2014;11:8. doi: 10.1186/1743-7075-11-8
   Google Scholar
• Hernández M, Garcia-Ramírez M, García-Rocha C, Saez-López C, Valverde AM, Guinovart JJ, et al. Glycogen storage in the human retinal pigment epithelium: a comparative study of diabetic and non-diabetic donors. Acta Diabetol 2014;51:543–52. doi: 10.1007/s00592-013-0549-8
   PubMed Web of Science ®Google Scholar
• Rajashekhar G, Ramadan A, Abburi C, Callaghan B, Traktuev DO, Evans-Molina C, et al. Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS One 2014;9:e84671. doi: 10.1371/journal.pone.0084671
   Google Scholar
• Elsherbiny NM, Ahmad S, Naime M, Elsherbini AM, Fulzele S, Al-Gayyar MM, et al. ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. Life Sci 2013;93:78–88. doi: 10.1016/j.lfs.2013.05.024
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Nawaz MI, Siddiquei MM, Siddiquei MM. High-mobility group box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina. Mediators Inflamm 2013; 863036. Doi:10.1155/2013/863036.
   Web of Science ®Google Scholar
• Rivera JC, Sitaras N, Noueihed B, Hamel D, Madaan A, Zhou T, et al. Microglia and interleukin-1β in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A. Arterioscler Thromb Vasc Biol 2013;33:1881–91. doi: 10.1161/ATVBAHA.113.301331
   PubMed Web of Science ®Google Scholar
• Huang J, Li X, Li M, Li J, Xiao W, Ma W, et al. Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats. Curr Mol Med 2013;13:935–45. doi: 10.2174/15665240113139990049
   PubMed Web of Science ®Google Scholar
• Omae T, Nagaoka T, Tanano I, Yoshida A. Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. Invest Ophthalmol Vis Sci 2013;54:4586–94. doi: 10.1167/iovs.13-11756
   PubMed Web of Science ®Google Scholar
• Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:3841–8.
   Web of Science ®Google Scholar
• He M, Pan H, Xiao C, Pu M. Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina. Invest Ophthalmol Vis Sci 2013;54:4092–101. doi: 10.1167/iovs.13-12004
   PubMed Web of Science ®Google Scholar
• Tan SM, Stefanovic N, Tan G, Wilkinson-Berka JL, de Haan JB. Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice. Invest Ophthalmol Vis Sci 2013;54:555–62. doi: 10.1167/iovs.12-10685
   PubMed Web of Science ®Google Scholar
• Ha Y, Saul A, Tawfik A, Zorrilla EP, Ganapathy V, Smith SB. Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1. Mol Vis 2012;18:2860–70.
   PubMed Web of Science ®Google Scholar
• Qiu F, He J, Zhou Y, Bai X, Wu G, Wang X, et al. Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy. Eye (Lond) 2014. Doi:10.1038/eye.2013.229.
   Web of Science ®Google Scholar
• Kowluru RA, Kowluru A, Veluthakal R, Mohammad G, Syed I, Santos JM, et al. TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy. Diabetologia 2014;57:1047–56. doi: 10.1007/s00125-014-3194-z
   PubMed Web of Science ®Google Scholar
• Cervellati F, Cervellati C, Romani A, Cremonini E, Sticozzi C, Belmonte G, et al. Hypoxia induces cell damage via oxidative stress in retinal epithelial cells. Free Rad Res 2014;48:303–12. doi: 10.3109/10715762.2013.867484
   PubMed Web of Science ®Google Scholar
• Fu D, Yu JY, Wu M, Du M, Chen Y, Abdelsamie SA, et al. Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes. J Lipid Res 2014;55:860–69. doi: 10.1194/jlr.M045401
   PubMed Web of Science ®Google Scholar
• Aung MH, Park HN, Han MK, Obertone TS, Abey J, Aseem F, et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci 2014;34:726–36. doi: 10.1523/JNEUROSCI.3483-13.2014
   PubMed Web of Science ®Google Scholar
• Nebbioso M, Pranno F, Pescosolido N. Lipoic acid in animal models and clinical use in diabetic retinopathy. Expert Opin Pharmacother 2013;14:1829–38. doi: 10.1517/14656566.2013.813483
   PubMed Web of Science ®Google Scholar
• Ola MS, Ahmed MM, Abuohashish HM, Al-Rejaie SS, Alhomida AS. Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. Neurochem Res 2013;38:1572–9. doi: 10.1007/s11064-013-1058-4
   PubMed Web of Science ®Google Scholar
• Zhang SY, Li BY, Li XL, Cheng M, Cai Q, Yu F, et al. Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice. Mol Vis 2013;19:812–21.
   PubMed Web of Science ®Google Scholar
• Tang J, Du Y, Lee CA, Talahalli R, Eells JT, Kern TS. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci 2013;54:3681–90. doi: 10.1167/iovs.12-11018
   PubMed Web of Science ®Google Scholar
• Dong LY, Jin J, Lu G, Kang XL. Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar Drugs 2013;11:960–74. doi: 10.3390/md11030960
   PubMed Web of Science ®Google Scholar
• Si YF, Wang J, Guan J, Zhou L, Sheng Y, Zhao J. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats. Brit J Pharmacol 2013;169:619–31. doi: 10.1111/bph.12163
   PubMed Web of Science ®Google Scholar
• Soufi FG, Mohammad-Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress-nuclear factor κB-apoptosis pathway. Pharmacol Rep 2012;64:1505–14. doi: 10.1016/S1734-1140(12)70948-9
   PubMed Web of Science ®Google Scholar
• Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R, et al. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc Res 2013;87:65–74. doi: 10.1016/j.mvr.2013.01.002
   PubMed Web of Science ®Google Scholar
• Silva KC, Rosales MA, Hamassaki DE, Saito KC, Faria AM, Ribeiro PA, et al. Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:1325–36. doi: 10.1167/iovs.12-10647
   PubMed Web of Science ®Google Scholar
• Du Y, Veenstra A, Palczewski K, Kern TS. Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Nat Acad Sci USA 2013;110:15586–91.
   Web of Science ®Google Scholar
• Gaspar JM, Martins A, Cruz R, Rodrigues CM, Ambrósio AF, Santiago AR. Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose. Neuroscience 2013;253:380–8. doi: 10.1016/j.neuroscience.2013.08.053
   PubMed Web of Science ®Google Scholar
• Rajalakshmi R, Amutha A, Ranjani H, Ali MK, Unnikrishnan R, Anjana RM, et al. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes. J Diabetes Complications 2014;28:291–7. pii: S1056-8727(13)00334-6. Doi:10.1016/j.jdiacomp.2013.12.008.
   PubMed Web of Science ®Google Scholar